Form 4: Anebulo Pharmaceuticals Director Granted Stock Options, Forms Power of Attorney

Bimal R. Shah, a director at Anebulo Pharmaceuticals, received stock options and granted a limited power of attorney for Section 16 reporting obligations.

Summary

• Bimal R. Shah, a director of Anebulo Pharmaceuticals, Inc., was granted stock options to purchase 31,618 shares of common stock on April 4, 2025.
• The exercise price for these options is $1.02 per share, and they expire on April 3, 2035.
• The options vest on the earlier of April 4, 2026, or the date of the 2026 annual meeting of shareholders.
• Shah also granted a limited power of attorney to Richard Cunningham or Daniel George of Anebulo Pharmaceuticals to handle SEC filings related to Section 16 reporting obligations.
• This power of attorney is effective until Shah is no longer required to file Forms 3, 4, and 5, or until revoked, or until the attorney-in-fact is no longer employed by the company.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures and insider transactions, which are generally viewed neutrally to positively as they indicate alignment of interests.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The power of attorney simplifies the process of SEC filings for the director.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the granting of stock options suggests an expectation of future value creation.

Industry Context

Stock options are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value. Section 16 filings are standard regulatory requirements for company insiders.

Comparison to Industry Standards

• Granting stock options to directors is a common practice in the pharmaceutical industry to incentivize performance and align interests with shareholders.
• Companies like Pfizer, Johnson & Johnson, and Merck also utilize stock options as part of their executive compensation packages.
• The vesting schedule and exercise price are typical for such grants.

Stakeholder Impact

• Shareholders may view the granting of stock options positively as it aligns the director's interests with the company's performance.
• The power of attorney simplifies administrative processes for the director.

Key Dates

Keywords

stock options, power of attorney, Form 4, Section 16, Anebulo Pharmaceuticals, director, beneficial ownership, SEC filings